 19. Has any unstable or uncontrolled cardiovascular, pulmonary, hepatic, renal, gastrointestinal GI, genitourinary, hematological, coagulation, immunological, endocrinemetabolic, or other medical disorder that, in the opinion of the investigator, would confound the study results or compromise participant safety. 